|
As reported, patient experienced wound dehiscence and treated with wound care post implant of galaflex 3d.Based on the information provided, no conclusions can be made.Wound dehiscence is a known inherent risk of surgery/use of the device and is included as a possible complication in the adverse reaction section of the instructions-for-use (ifu).Review of manufacturing records confirms product was manufactured to specification.This mdr reports the ae of right breast (device #1).An additional mdr was submitted to report the ae of left breast (device #2).Note, the date of event (24-apr2024) is considered to be a best estimate based on the date of awareness.Note: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : not returned - remains implanted.
|
|
As reported, the patient underwent a bilateral mastopexy with breast implants and a galaflex 3d.It was reported that the patient experienced bilateral incisional wound dehiscence post-operatively.The patient was treated with wound care and the right breast was healed; however, on the left breast side, the wound remains open and did not appear to be incorporating.As reported, surgeon is considering a revision procedure to possibly remove the mesh bilaterally.
|